Verve Therapeutics Inc (VERV)

33.15 -2.59  -7.25% NASDAQ Nov 26, 16:00 USD

Verve Therapeutics Underperform Recommendations

View 4,000+ financial data types

Historical Underperform Recommendations Data

View and export this data going back to 2021. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Nov. 15, 2021 Upgrade
Nov. 12, 2021 Upgrade
Nov. 10, 2021 Upgrade
Nov. 9, 2021 Upgrade
Nov. 5, 2021 Upgrade
Oct. 25, 2021 Upgrade
Sept. 24, 2021 Upgrade
Sept. 23, 2021 Upgrade
Sept. 2, 2021 Upgrade
Aug. 12, 2021 Upgrade
July 13, 2021 Upgrade
July 12, 2021 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

View Underperform Recommendations for VERV

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Underperform Recommendations Range, Past 5 Years

Minimum Upgrade Jul 12 2021
Maximum Upgrade Jul 12 2021
Average Upgrade


Verve Therapeutics' Q3 Net Loss Shrinks
MT Newswires 11/10 07:51 ET
Top IPO additions to Russell 2000 Index
SA Breaking News 09/17 10:48 ET
WHO urges fair access to gene-editing technologies
SA Breaking News 07/12 11:51 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.